PreOmics: Funding, Investors & Team (Aug 2026)
PreOmics develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs. PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. They at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Their mission is to provide you with the best possible solutions and at the highest quality to achieve your results faster, easier and in a more robust manner than ever before.
PreOmics has raised $15.3M across 1 funding round on record, the most recent a Series B of $15.3M announced in Jan 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PreOmics Company Profile and Key Stats
Latest funding round on record: Jan 2022.
PreOmics Funding Rounds
PreOmics Founders and Leadership Team
Contact details for the PreOmics team: 1 of 1 has an email address on file.
Start 14-day free trial →PreOmics Funding Compared to Other Biotechnology Startups
PreOmics' latest round of $15.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PreOmics in Biotechnology and Martinsried
Companies Similar to PreOmics
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
PreOmics Funding FAQs
What does PreOmics do?
PreOmics develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs. PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. They at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Their mission is to provide you with the best possible solutions and at the highest quality to achieve your results faster, easier and in a more robust manner than ever before.
How much funding has PreOmics raised?
PreOmics has raised $15.3M across 1 round on record. The most recent is a Series B of $15.3M announced in Jan 2022.
When did PreOmics last raise funding?
PreOmics' most recent funding round on record is a Series B of $15.3M, announced in Jan 2022.
Who is the CEO of PreOmics?
Garwin Pichler is listed as CEO at PreOmics.
Where is PreOmics headquartered?
PreOmics is based in Martinsried, Bayern, Germany.
How many employees does PreOmics have?
PreOmics is in the 11-50 employee band.
How does PreOmics' funding compare to other Biotechnology startups?
PreOmics' latest round of $15.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's PreOmics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PreOmics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.